A new take on growth factor signaling in tamoxifen resistance

Courtesy EurekAlert! - Cancer  Mon, 06/22/2009 - 22:00

(BioMed Central) Differences in growth factor (GF) signaling may cause the poor prognosis in some breast cancer cases.

A new study, published in the open-access journal BMC Medical Genomics, suggests that some estrogen receptor-positive breast cancers respond poorly to tamoxifen because of increased GF signaling.

Tags:

 

More related items

Salk scientists use an old theory to discover new...
(Salk Institute) Reviving a theory first proposed in the late 1800s that the development of organs in the normal embryo and the development of cancers are related, scientists at the Salk...

Studies: Avastin may fight early breast cancers
Surprising results from two new studies may reopen debate about the value of Avastin for breast cancer. The drug helped make tumors disappear in certain women with early-stage disease,...

Studies: Avastin may fight early breast cancers
Studies: Avastin may fight early breast cancers Associated Press Copyright 2012 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or...

Burt's Bees Free Head to Toe Starter Kit

Lobe Wonder Ear Support Patches For Earrings,...


 

Post new comment

The content of this field is kept private and will not be shown publicly.
health-fitness.marc8.com